Impel Pharmaceuticals Inc.
IMPL · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$106,312 | -$76,536 | -$45,798 | -$41,859 |
| Dep. & Amort. | $1,201 | $1,088 | $1,077 | $722 |
| Deferred Tax | $0 | $2,133 | $153 | $0 |
| Stock-Based Comp. | $5,191 | $3,130 | $3,641 | $794 |
| Change in WC | -$13,007 | $2,214 | $1,536 | $3,214 |
| Other Non-Cash | $19,285 | $1,607 | $208 | $642 |
| Operating Cash Flow | -$93,642 | -$66,364 | -$39,183 | -$36,487 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,377 | -$408 | -$1,782 | -$1,523 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1,377 | -$408 | -$1,782 | -$1,523 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,253 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $67,461 | $147,889 | $11,059 | $21 |
| Financing Cash Flow | $67,461 | $147,889 | $11,059 | $21 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$27,558 | $81,117 | -$29,906 | -$37,989 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88,212 | $7,095 | $37,001 | $74,990 |
| End Cash | $60,654 | $88,212 | $7,095 | $37,001 |
| Free Cash Flow | -$95,019 | -$66,772 | -$40,965 | -$38,010 |